Catalyst Grant : Cannabis Research in Urgent Priority Areas – Full Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Thursday 4th, October 2018
External Deadline: Wednesday 10th, October 2018
Description
| Registration Deadline | 2018-09-18 |
|---|---|
| Application Deadline | 2018-10-10 |
The purpose of this current funding opportunity is to strengthen the evidence base and expand cannabis research in these identified areas, to build cannabis-related research capacity and/or to inform the development of future larger scale research projects. Specifically, this funding opportunity will support projects relevant to the following:
- Neurodevelopment: Neurodevelopmental outcomes associated with cannabis use (e.g., resulting from use and/or exposure during preconception, pregnancy and breastfeeding on the fetus, child and youth).
- Prevention, harm reduction and treatment of problematic cannabis use: Research into effective interventions to prevent problematic use, to reduce the harms of use and to treat the full spectrum of problematic cannabis use.
- Potency and product safety: Toxicity/potency, product standards and the balance of cannabinoids to minimize harms and maximize benefits.
- Social determinants of health and key populations: Research into how use and related health and psychosocial effects vary by sex, social determinants of health(e.g., gender, income, housing, social support, etc.) and/or sub-population (e.g., youth, older adults, Indigenous peoples, pregnant people, workplace users, those with co-morbid conditions, those using prescribed cannabis, etc.). Beyond the explicit topic, “Social determinants of health and key populations”, applicants are encouraged to critically assess the state of knowledge on the biological and social determinants of health and/or on sub-population(s) across all research areas.
- Mental health: Relationship between cannabis use and mental health (e.g., post-traumatic stress, psychosis, anxiety, depression, addiction, co-morbid conditions, etc.), including both potential harms and/or benefits.
- Cannabis and other drug: substance use: Research into the health outcomes of cannabis use and other drug/substance use (i.e., polysubstance use), includin the use of recreational and/or prescribed cannabis in the context of illicit and/or prescribed opioids.
- Cannabis and pain management: Research into the potential therapeutic use of cannabis (recreational or prescribed) for pain management.
For additional details on this program, please visit CIHR’s website.